Regenxbio Inc (RGNX)
- Exchange
- NASDAQ
- Symbol
- RGNX
- Sector
- Life Sciences
- Industry
- Biological Products, (no Disgnostic Substances)
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, offers candidate gene therapy products to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies intended to affect disease. The company is headquartered in Rockville, Maryland.
- Country
- USA
Stock price
At close: November 20, 2024
-
Open9.56
-
High9.80
-
Low9.01
-
Close9.63
-
Volume804,939
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
—
Receivables turnover
3.45
Payables turnover
6.05
Working capital turnover
0.42
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
105.72
Number of days of payables
60.29
Fixed asset turnover
0.65
Total asset turnover
0.15
Current ratio
2.57
Quick ratio
2.60
Cash ratio
2.41
Cash conversion cycle
45.43
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.84
Interest coverage
-39.07
Gross profit margin
-61.19%
Operating profit margin
-313.29%
Pretax margin
-308.05%
Net profit margin
-307.87%
Operating return on assets (Operating ROA)
-46.71%
Return on assets (ROA)
-45.91%
Return on total capital
-86.01%
Return on equity (ROE)
-84.52%